{
  "schemaVersion": 1,
  "id": "research-103",
  "slug": "103-what-the-2026-epitalon-review-says-about-sleep-research",
  "title": "What the 2026 Epitalon Review Says About Sleep Research",
  "catalogLabel": "Epitalon",
  "productCollection": "https://heritagebiolabs.com/research-library/products/epitalon",
  "productHandles": [
    "epitalon-565"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/epitalon-565"
  ],
  "readingFocus": "Study findings",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 290,
  "sourceYears": [
    2026
  ],
  "paragraphs": [
    "Peptides are short chains made of amino acids connected by peptide bonds. Some are studied for changes in chemical signals that vary across the day. Epitalon is the four-amino-acid peptide Ala-Glu-Asp-Gly. Interest in its possible influence on circadian biology has prompted studies of markers associated with the body clock. A change in a marker related to melatonin does not by itself answer whether someone with insomnia sleeps better. [1]",
    "The FDA examined that distinction in its July 2026 briefing on epitalon and epitalon acetate. The reviewers identified small human reports involving people who worked night shifts. They described measures such as expression of genes involved in timing and a urinary product of melatonin breakdown. Such measurements can tell researchers about a particular signal or time pattern. To assess insomnia, a trial would also need outcomes that describe the disorder: difficulty falling or staying asleep and the consequences for daily function. FDA did not identify studies evaluating effectiveness for insomnia or studies using the route proposed in the nomination. [1]",
    "Later in 2026, HHS published an interim policy describing circumstances in which it does not intend to take certain enforcement actions related to compounding selected peptide substances, including specified epitalon acetate. The policy addresses conditions such as material identity and use by eligible compounders. It did not approve the peptide as a drug or establish that it improves sleep. A policy document and a clinical experiment answer different questions. [2, 3]",
    "The clearest research question is therefore a narrow one: can a defined epitalon preparation change a prespecified sleep outcome in a well-controlled study of people with the relevant condition? Measurements of timing signals can help explain a result if that study is done. They cannot substitute for that comparison. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "US Food and Drug Administration. FDA Briefing Document for Epitalon-Related Bulk Drug Substances. Pharmacy Compounding Advisory Committee (2026-07-23).",
      "url": "https://www.fda.gov/media/193345/download"
    },
    {
      "number": 2,
      "citation": "US Department of Health and Human Services. HHS Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances (2026-10-30).",
      "url": "https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf"
    },
    {
      "number": 3,
      "citation": "US Department of Health and Human Services. Enforcement Discretion Policy Regarding 503A Compounding Using Certain Peptide Bulk Drug Substances. Federal Register (2026-10-30).",
      "url": "https://www.govinfo.gov/content/pkg/FR-2026-10-30/pdf/2026-22192.pdf"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/103-what-the-2026-epitalon-review-says-about-sleep-research",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/103-what-the-2026-epitalon-review-says-about-sleep-research.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/103-what-the-2026-epitalon-review-says-about-sleep-research.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 021 - Epitalon and Follistatin 315.docx",
    "sourceArticleNumber": 103,
    "contentSha256": "349e2ada83952abf937bd32eadc5a430231609529d3175a0fe2b369e7792a630",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
